Bioreductive agents, hypoxic cells and therapy

被引:12
作者
Connors, TA
机构
关键词
D O I
10.1016/0959-8049(96)00305-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1833 / 1834
页数:2
相关论文
共 10 条
  • [1] A MARKER FOR HYPOXIC CELLS IN TUMORS WITH POTENTIAL CLINICAL APPLICABILITY
    CHAPMAN, JD
    FRANKO, AJ
    SHARPLIN, J
    [J]. BRITISH JOURNAL OF CANCER, 1981, 43 (04) : 546 - 550
  • [2] Development of new markers for hypoxic cells: [I-131]iodomisonidazole and [I-131]iodoerythronitroimidazole
    Cherif, A
    Wallace, S
    Yang, DJ
    Newman, RA
    Harrod, VI
    Nornoo, A
    Inoue, T
    Kim, CG
    Kuang, LR
    Kim, EE
    Podoloff, DA
    [J]. JOURNAL OF DRUG TARGETING, 1996, 4 (01) : 31 - &
  • [3] EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC early clinical studies group
    Dirix, LY
    Tonnesen, F
    Cassidy, J
    Epelbaum, R
    Huinink, WWT
    Pavlidis, N
    Sorio, R
    Gamucci, T
    Wolff, I
    TeVelde, A
    Lan, J
    Verweij, J
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (11) : 2019 - 2022
  • [4] PHARMACOKINETICS AND BINDING OF THE BIOREDUCTIVE PROBE FOR HYPOXIA, NITP - EFFECT OF ROUTE OF ADMINISTRATION
    HODGKISS, RJ
    STRATFORD, MRL
    DENNIS, MF
    HILL, SA
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (06) : 1462 - 1468
  • [5] POSITRON EMISSION TOMOGRAPHY STUDIES IN PATIENTS WITH LOCALLY ADVANCED AND/OR METASTATIC BREAST-CANCER - A METHOD FOR EARLY THERAPY EVALUATION
    JANSSON, T
    WESTLIN, JE
    AHLSTROM, H
    LILJA, A
    LANGSTROM, B
    BERGH, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (06) : 1470 - 1477
  • [6] Kilpatrick D., 1996, Proceedings of the American Association for Cancer Research Annual Meeting, V37, P604
  • [7] Ross D, 1996, BRIT J CANCER, V74, pS1
  • [8] A NEW PERFLUOROCARBON FOR USE IN F-19 MAGNETIC-RESONANCE-IMAGING AND SPECTROSCOPY
    SOTAK, CH
    HEES, PS
    HUANG, HN
    HUNG, MH
    KRESPAN, CG
    RAYNOLDS, S
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1993, 29 (02) : 188 - 195
  • [9] WILCOX WS, 1968, PHARM PRINCIPLES ANT, P25
  • [10] WORKMAN P, 1994, ONCOL RES, V6, P461